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Abstract
Objective
To describe the distribution of specific mitochondrial DNA (mtDNA) haplogroups (hgs) in a
cohort of patients with rheumatoid arthritis (RA).
Methods
Two-hundred nineteen consecutive patients with RA had mtDNA isolated from their blood,
sequenced and haplotyped. Patients were diagnosed according to the American College of
Rheumatology (ACR)/European league against Rheumatism (EULAR) criteria. Demo-
graphic and clinical data were retrieved from the Danish nationwide database (DANBIO).
Logistic regression analyses were performed to test for associations.
Results
One-hundred eighty-four patients were eligible for analysis. Haplogroup frequencies were:
H (n = 88; 47.8%), U (n = 37; 20.1%), T (n = 22; 12.0%), J (n = 16; 8.7%), K (n = 11; 5.9%),
HV (n = 6; 3.3%) and V (n = 4; 2.2%). The distribution of individual hgs was identical to the
background population. Radiographic erosions were significantly associated with hg clus-
ters JT (OR = 2.37, 95% confidence interval (CI): 1.07–5.53, p = 0.038). Significantly fewer
patients from hg cluster JT received biological treatment (OR = 0.17, 95% CI: 0.03–0.87, p =
0.038). Albeit, none of these associations were significant when corrected for multiple tests.
Conclusion
There was no significant association between mtDNA hgs and presence of RA or disease
manifestations. There was an, albeit insignificant, overrepresentation of patients with hg JT
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among patients with erosive disease; however, slightly fewer patients in the JT group were
treated with biological drugs.
1. Introduction
Mitochondrial DNA (mtDNA) has a strict maternal mode of inheritance and is not subject to
recombination [1]. Every mitochondrion contains from 2–5 copies of mtDNA [1]. Through-
out evolution mutations have accumulated sequentially in the 16.6 kb mtDNA genome leading
to the fixation of haplogroups (hgs) [1,2]. Individual hgs are defined by the combination of sin-
gle nucleotide polymorphisms (SNP) and are named from hg A to hg Z [1,3].
mtDNA encodes for proteins involved in the mitochondrial production of adenosine tri-
phospate (ATP) by oxidative phosphorylation (OXPHOS), a process also involved in genera-
tion of superoxide and other reactive oxygen species (ROS) [1–3]. Furthermore, the
mitochondria are of importance for apoptosis, calcium handling and several intracellular sig-
nalling pathways [4,5]. Mutations in mtDNA have been recognised as causes of disease often
involving organs with high energy turnover [4]. This has resulted in the formulation of a bio-
energetic paradigm suggesting that variation in mtDNA may lead to changes in oxidative stress
in cells and eventually to differences in morbidity, mortality, and longevity [4–6].
Several studies have investigated the association between hgs and various diseases [1,2,7–
12]. Rego-Perez et al. found that mtDNA haplogroup (hg) J lowered the risk for osteoarthritis
(OA) in the knees and hips [10] and others have found that hgs J and K are associated with a
reduced risk of Parkinson’s disease [8]. Furthermore, hg U has been linked with Alzheimer’s
disease [9], and hgs H and HV have been associated with the development of hypertrophic car-
diomyopathy [1]. Recently, a large study identified several mtDNA SNPs each associated with
several degenerative diseases such as Parkinson’s disease, multiple sclerosis and ischaemic
stroke [13].
Rheumatoid arthritis (RA) is a chronic auto-immune disorder which is characterized by
synovial inflammation and hyperplasia, autoantibody production, cartilage and bone destruc-
tion leading to erosions and joint deformity [14]. A recent study has suggested ROS to be
involved in the pathogenesis of RA [15], but whether this relates to associations between RA
and the mtDNA hgs have not previously been investigated. The aim of this study was to ana-
lyse the distribution of mtDNA hgs in a cohort of patients with RA according to disease phe-
notype, presence of rheumatoid factor, and biological treatment. The distribution of mtDNA
hgs in the RA-cohort was compared with two historical control groups from the background
population.
2. Materials and methods
2.1. Study population and data collection
Consecutive randomly selected patients treated for RA in the out-patient clinic at the Depart-
ment of Rheumatology, Frederiksberg Hospital, Copenhagen, Denmark between January-
December 2013 were assessed for inclusion. Inclusion criteria were fulfilment of the classifica-
tion criteria for RA proposed by the American College of Rheumatology (ACR) in 1987 and
European league against Rheumatism (EULAR) in 2010 [16], age above 18 years and written
informed consent to have blood analysed for mtDNA haplotyping and to have data extracted
from relevant databases. Exclusion criterion was a non-European hg e.g. only patients with hg
H, hg HV, hg V, hg U, hg K, hg J or hg T were included [17]. This exclusion was performed to
avoid that the association analysis should be skewed due to population stratification.
Mitochondrial haplogroups and RA
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Demographic and clinical data were extracted from the nationwide DANBIO database
(The National Danish Registry for Biological Treatment of Rheumatic Diseases), which con-
tains prospective data on all adult Danish rheumatologic patients subjected to both biologi-
cal treatment and conventional treatment with synthetic disease modifying anti-rheumatic
drugs (sDMARD). Data included gender, age, IgM rheumatoid factor (IgM-RF) and anti-
cyclic citrullinated peptide (anti-CCP) status, radiographic joint erosions and whether the
patients were receiving biological/sDMARDs treatment. Furthermore, the disease activity
score 28-joints with c-reactive protein (DAS28-CRP) was registered. By convention
DAS28-CRP levels can be graded in four categories according to the disease score: “High
disease activity” (> 5.1), “Moderate disease activity” (3.2  5.1), “Low disease activity”
(2.6  3.2) and “Remission” (< 2.6) [18]. Biological treatment is considered when the
patient has current and persistent moderate or high disease activity [19]. Therefore, when
testing the associations between clinico-pathological factors and allocation to biological
treatment the DAS28-CRP was divided into”remission/mild” or “moderat/severe” disease
activity. Biological treatment may also be considered if x-ray show current, progressive ero-
sions regardless of the DAS28-CRP [19].
The distribution of the mtDNA hgs in the study population were compared with results
from two other Danish studies performed in the Greater Copenhagen area, Denmark. The
study by Benn et al. examined mtDNA hg distribution in 9254 patients from the Copenhagen
City Heart Study [6]. The other study by Mikkelsen et al. analysed the mtDNA hg distribution
from 206 employees at the Department of Forensic Medicine, Faculty of Health Sciences, Uni-
versity of Copenhagen and the Danish Police force [20].
2.2 mtDNA haplotyping
DNA was extracted from the blood using the Maxwell1 16 system (Promega Corporation,
Madison, Wisconsin, USA). Polymerase Chain Reaction (PCR) and pyrosequencing primers
for mtDNA haplotyping were designed using PyroMark Assay Design 2.0 and the revised
Cambridge Reference Sequence (rCRS) (NC_012920) as template. The combination of diag-
nostic SNPs used for mtDNA haplotyping of European mitochondrial hg H, hg U, hg K, hg J,
hg T, and hg V is presented in Table 1. The hgs were classified according to PhyloTree.org
(mtDNA tree Build 16 (19th of February 2014)) [1,17].
2.3 Statistical analysis
Due to small sample sizes we pooled the hgs into evolutionary closely related hg clusters: HV,
UK and JT.
Table 1. European mitochondrial haplogroups [1–2,17].
rCRS position Diagnostic SNP for haplogroup (variant)
7028 H (C); U, K, J, T, V, HV (T)
11467 K, U (G); H, J, T, V, HV (A)
10550 K (G); H, U, J, T, HV, V (A)
15607 T (G); H, U, K, J, HV, V (A)
16069 J (T); H, U, K, T, HV, V (C)
11251 J, T (G); H, U, K, HV, V (A)
4580 V (A); H, U, K, J, T, HV (G)
14766 HV, V (C); H, U, K, J, T (T)
rCRS: revised Cambridge Reference Sequence; SNP: single nucleotide polymorphism.
https://doi.org/10.1371/journal.pone.0188492.t001
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Logistic regression analyses were performed to test for associations between the hg clusters
and anti-CCP (negative/positive), IgM-RF (negative/positive), DAS28-CRP (remission/mild
or moderate/severe), erosions (absent/present) and biological treatment (no/yes). Multivari-
able analyses were performed of associations between clinico-pathological factors and alloca-
tion to biological treatment. A two-tailed p-value of 0.05 was used as level of significance. The
results are presented in odds ratio (OR). Statistical analyses were performed in R version
2.15.2 [21].
2.4 Ethics statement
The Regional Ethics Committee of Copenhagen (M-20100153) and the Danish Data Protec-
tion Agency (J. 2010-41-4719) approved this study. The study was conducted in accordance
with the Declaration of Helsinki. Patients did not give informed consent as the samples were
taken as part of routine medical care. This in accordance with the permission from the
Regional Ethics Committee of Copenhagen and The Declaration of Helsinki, para 32. The
authors were not involved in drawing blood and collecting of samples, but the samples were
blinded prior to laboratory analyses.
3. Results
In total, 219 patients were included. They were diagnosed with seropositive RA (n = 185), sero-
negative RA (n = 33), or juvenile arthritis (n = 1). Thirty-five patients were excluded from
analysis due to having a non-European hg (n = 29) or an unknown hg (n = 6). The distribution
of mtDNA hgs and hg clusters was analysed in all included patients.
Patient demographics and clinical data stratified by the hgs and hg clusters are presented in
Table 2. Median age was 60.5 years (interquartile range 22–88 years).
The hg frequencies are shown in Table 3. Furthermore, hg frequencies from two control
groups from the background population are listed in Table 3 [6,20]. In the study by Benn et al.
no data on the hg HV [6] were available. Mikkelsen et al. had no data on hg V [20]. The distri-
bution of individual hgs was comparable with the distribution of the background populations.
A significant association between hg clusters and disease activity was found with regard to
erosions as patients with hgs in cluster JT showed a significantly higher frequency of erosions
(OR = 2.37, 95% CI: 1.07–5.53, p = 0.038) compared to hg cluster HV, Table 4.
None of the hg clusters were significantly associated with anti-CCP, IgM-RF, DAS28-CRP
or biological treatment (Table 4).
When testing the multivariable association between clinico-pathological factors and alloca-
tion to biological treatment in Table 5, there were significantly fewer patients from hg cluster
JT that received biological treatment (OR = 0.17, 95% CI: 0.03–0.87, p = 0.038). There was a
borderline significant association between getting biological treatment and having erosions
(OR = 3.61, 95% CI: 1.04–14.45, p = 0.050) and a significant association between biological
treatment and having moderate/severe DAS28-CRP (OR = 35.83, 95% CI: 10.18–164.94,
p< 0.001). No association was found between biological treatment and anti-CCP or IgM-RF
(Table 5).
4. Discussion
This study investigated the distribution of mtDNA hgs in patients with RA according to dis-
ease activity, presence of rheumatoid factor (and/or anti-CCP antibodies), and biological treat-
ment. The distribution of mtDNA hgs in the RA-cohort was compared with two historical
control groups from the background population and the overall distribution of hgs was found
Mitochondrial haplogroups and RA
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to be comparable with the distribution of the background populations. Thus, there does not
seem to be an association between the occurrence of RA and mtDNA hgs.
The study demonstrated an association albeit insignificant following Bonferroni’s correc-
tion for multiple testing, between radiographic erosions and the hg cluster JT. However, the
multivariable analysis showed that significantly fewer patients from the hg cluster JT received
biological treatment compared to hg cluster HV. Furthermore, there was a significant associa-
tion between biological treatment and having moderate/severe DAS28-CRP, but only border-
line significance was obtained when radiographic erosions were included in the calculations.
The hg cluster JT had a higher frequency of erosions compared to hg cluster HV.
Table 2. Patient characteristics according to haplogroups and haplogroup clusters.
Total HV H V Cluster HV U K Cluster UK T J Cluster TJ
184 6 88 4 98 37 11 48 22 16 38
Gender:
Female 137 5 61 3 69 28 10 38 19 11 30
Male 47 1 27 1 29 9 1 10 3 5 8
Age groups (years):
40 22 2 12 0 14 2 1 3 2 3 5
>40–50 24 2 9 0 11 7 1 8 3 2 5
>50–60 46 2 22 3 27 6 5 11 8 0 8
>60–70 49 0 25 0 25 12 2 14 3 7 10
>70–80 36 0 19 1 20 6 1 7 5 4 9
>80 7 0 1 0 1 4 1 5 1 0 1
Anti-CCP:
ND# 45 0 24 0 24 10 3 13 3 5 8
Positive 108 5 51 3 59 20 7 27 12 10 22
Negative 31 1 13 1 15 7 1 8 7 1 8
IgM-RF:
ND# 16 0 6 0 6 5 2 7 2 1 3
Positive 146 4 76 3 83 26 9 35 14 14 28
Negative 22 2 6 1 9 6 0 6 6 1 7
DAS28-CRP:
ND# 1 0 1 0 1 0 0 0 0 0 0
Remission (<2.6) 34 0 16 1 17 10 2 12 2 3 5
Mild (2.63.2) 13 0 8 0 8 1 1 2 0 3 3
Moderate (3.25.1) 74 3 31 2 36 17 4 21 11 6 17
Severe (>5.1) 62 3 32 1 36 9 4 13 9 4 13
Erosions:
ND# 10 0 3 1 4 3 1 4 2 0 2
Present 97 1 43 2 46 19 7 26 14 11 25
Absent 77 5 42 1 48 15 3 18 6 5 11
Biological treatment:
ND# 1 0 1 0 1 0 0 0 0 0 0
Yes 131 6 65 4 75 23 8 31 17 8 25
No 52 0 22 0 22 14 3 17 5 8 13
# Not defined/No registered data.
Anti-CCP: anti-cyclic citrullinated peptide; IgM-RF: IgM rheumatoid factor; DAS28-CRP: disease activity score 28-joints with c-reactive protein; Erosions:
radiographic joint erosions.
https://doi.org/10.1371/journal.pone.0188492.t002
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Thus, our results might indicate that patients in hg cluster JT exhibit a higher disease activ-
ity. This may be a consequence of the small study sample, as hg H has been associated with
increased pathogenicity in degenerative diseases compared to other hgs. A study by Soto-Her-
mida et al. evaluated the influence of the mtDNA hgs on the progession of knee OA and found
cartilage thickness loss to be significantly lower in patients with hgs T [11]. They suggested
mtDNA hg T to have a higher capacity to cope with oxidative stress than hg H [11]. This was
supported by two other studies indicating a higher vulnerability of hg H to ROS than hg T
[22,23]. Previous studies have shown that higher energy turnover of the cell and protonmotive
force is positively correlated to ROS production [24,25]. Thereby expecting the HV cluster to
associate with a higher amount of erosions.
An imbalance between ROS production and elimination is thought to lead to the oxidative
stress in RA patients which contributes to tissue damage and further to the chronicity of the
disease [26]. Oxidative stress has therefore been considered to be involved in the onset of RA
[15,26–29].
Table 3. The frequencies and distribution of mtDNA haplogroups in the rheumatoid arthritis patient cohort and two control cohorts from the Dan-
ish background population.
RA cohort
n = 184 (%)
Benn et al.
n = 8451 (%)
Mikkelsen et al.
n = 177 (%)
Haplogr.cluster HV
hg HV 6 (3.3) - - 7 (4.0)
hg H 88 (47.8) 4244 (50.2) 82 (46.3)
hg V 4 (2.2) 412 (4.9) - -
Total 98 (53.3) 4656 (55.1) 89 (50.3)
Haplogr.cluster UK
hg U 37 (20.1) 1469 (17.4) 26 (14.7)
hg K 11 (5.9) 571 (6.8) 20 (11.3)
Total 48 (26.0) 2040 (24.2) 46 (26.0)
Haplogr.cluster JT
hg T 22 (12.0) 912 (10.8) 17 (9.6)
hg J 16 (8.7) 843 (9.9) 25 (14.1)
Total 38 (20.7) 1755 (20.7) 42 (23.7)
RA: rheumatoid arthritis; Benn et al.: Benn M, Schwartz M, Nordestgaard BG, Tybjærg-Hansen A. Mitochondrial haplogroups: Ischemic cardiovascular
disease, other diseases, mortality, and longevity in the general population. Circulation. 2008; 117: 2492–2501. 10.1161/CIRCULATIONAHA.107.756809
18458168. [6]; Mikkelsen et al.: Mikkelsen M, Sørensen E, Rasmussen EM, Morling N. Mitochondrial DNA HV1 and HV2 variation in Danes. Forensic Sci Int
Genet. 2010; 4: 87–88. 10.1016/j.fsigen.2009.07.007 20457038. [20].
https://doi.org/10.1371/journal.pone.0188492.t003
Table 4. Associations between haplogroup clusters and univariable clinicopathological data.
Erosions DAS28-CRP Anti-CCP IgM-RF Bio.treatment
OR (95% CI) P OR (95% CI) P OR (95% CI) P OR (95% CI) P OR (95% CI) P
HV 1.00 1.00 1.00 1.00 1.00
UK 1.51 0.73–3.14 0.267 0.84 0.39–1.85 0.665 0.86 0.33–2.35 0.757 0.88 0.29–2.99 0.823 0.53 0.25–1.15 0.106
JT 2.37 1.07–5.53 0.038 1.30 0.54–3.38 0.567 0.70 0.26–1.94 0.478 0.49 0.17–1.46 0.183 0.56 0.25–1.30 0.172
OR = Odds Ratio; CI = Confidence Interval; P: p-value; Erosions: radiographic joint erosions; DAS28-CRP: disease activity score 28-joints with c-reactive
protein; Anti-CCP: anti-cyclic citrullinated peptide; IgM-RF: IgM rheumatoid factor; Bio.treatment: biological treatment.
https://doi.org/10.1371/journal.pone.0188492.t004
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Measurements on oxidative stress have been challenging, but studies have been performed
to analyse whether mtDNA hgs differ in ROS production [22,30–32]. A comparison of the
findings of these studies is complicated by the variation in the choice of models, methods and
design used. The ROS production have been measured in transmitochondrial cybrids using
fluorogenic dyes as MitoSOX and H2DCFDA [30–32]. The cybrid cell-lines were not the same
in these studies and the flourogenic dyes have been found controversial as a method for mea-
suring mitochondrial ROS production [33,34]. The mitochondrial ROS production is linked
to the mitochondrial membrane potential, that is connected to the rate of OXPHOS [35]. The
variation that may exist in OPXHOS function in different hgs is coupled to variation in ROS
production. The OXPHOS function in hgs have been analysed using respirometry
[30,32,36,37], respiratory gas-exchange [23,38,39], enzymatic assays [22], in cybrids
[22,30,32,37], humans [23,38,39], and permeabilized muscle cells [36]. Interestingly, hgs UK
and H have been studied by a similar method by Gomez-Duran [32], and Larsen [36], in
cybrids and permeabilized muscle fibers, reaching opposite conclusions. This indicates vari-
ability in OXPHOS function between mtDNA hgs [23,30,32,36]. There is evidence that ROS
are involved in cartilage degradation in vitro and in animal OA models. [40].
A study by Mitsunaga et al. found a significant association between severe erosive RA and
mitochondrial respiratory complex-related genes, that were major site of ROS generation [15].
They suggested that ROS were involved in cartilage and bone destruction through activation
of osteoclast and fibroblast-like synoviocytes [15].
To our knowledge only one study by Coto-Segura et al. has examined the hgs frequencies in
patients with arthritis—psoriatic arthritis (PsA) [41]. Comparing the most common hg H with
hg J, they found that hg J was significantly less frequent among patients with PsA,
Table 5. Multivariable analysis of associations between clinicopathological factors and allocation to
biological treatment.
Biological treatment
OR (95% CI) P
Haplogroup cluster:
HV 1.00
UK 0.52 0.11–2.32 0.385
JT 0.17 0.03–0.87 0.038
Erosion:
Absent 1.00
Present 3.61 1.04–14.45 0.050
DAS28-CRP:
Remission/mild 1.00
Moderate/severe 35.83 10.18–164.94 <0.001
Anti-CCP:
No 1.00
Yes 0.70 0.07–4.99 0.740
IgM-RF:
No 1.00
Yes 0.35 0.01–3.71 0.439
OR = Odds Ratio; CI = Confidence Interval; P: p-value; Erosions: radiographic joint erosions; DAS28-CRP:
disease activity score 28-joints with c-reactive protein; Anti-CCP: anti-cyclic citrullinated peptide; IgM-RF:
IgM rheumatoid factor.
https://doi.org/10.1371/journal.pone.0188492.t005
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hypothesising a protective effect in their study population [41]. Other studies support the pro-
tective effects of hg J when regarding the development of OA [7,10,12].
Our findings, that there are not any significant association between European mtDNA nei-
ther with occurrence of RA nor with clinical manifestations may reflect the complexity of RA
etiology and pathogenesis, as the mtDNA variation most likely involves many other mitochon-
drial functions. It is probably not sufficient to interpret the results with reference solely to ROS
production. Finally, mtDNA only code for approximately 1% of the mitochondrial proteome
[42], so population substratification may also confound the results. However, more studies are
needed to confirm our findings and more carefully relate them to clinical and biochemically
defined subtypes of RA.
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